William Blair Investment Management LLC Boosts Stock Holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

William Blair Investment Management LLC raised its holdings in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 44.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 812,825 shares of the company’s stock after buying an additional 248,888 shares during the period. William Blair Investment Management LLC owned about 2.90% of Establishment Labs worth $37,447,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of ESTA. Mudita Advisors LLP raised its stake in shares of Establishment Labs by 19.0% during the third quarter. Mudita Advisors LLP now owns 354,801 shares of the company’s stock valued at $15,352,000 after acquiring an additional 56,700 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its stake in shares of Establishment Labs by 1.8% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 35,236 shares of the company’s stock valued at $1,525,000 after purchasing an additional 632 shares in the last quarter. Stonepine Capital Management LLC bought a new position in shares of Establishment Labs during the third quarter valued at approximately $3,245,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in shares of Establishment Labs by 89.5% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 41,351 shares of the company’s stock valued at $1,789,000 after purchasing an additional 19,531 shares in the last quarter. Finally, Vestal Point Capital LP purchased a new stake in shares of Establishment Labs during the third quarter valued at approximately $1,731,000. 72.91% of the stock is owned by institutional investors.

Establishment Labs Trading Up 6.0 %

Shares of ESTA stock opened at $39.27 on Tuesday. Establishment Labs Holdings Inc. has a 1 year low of $28.16 and a 1 year high of $60.12. The firm has a fifty day moving average price of $36.29 and a 200-day moving average price of $40.98. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. The company has a market cap of $1.13 billion, a price-to-earnings ratio of -15.22 and a beta of 0.95.

Establishment Labs (NASDAQ:ESTA) last posted its quarterly earnings data on Wednesday, February 26th. The company reported ($0.98) EPS for the quarter, missing the consensus estimate of ($0.64) by ($0.34). The company had revenue of $44.51 million during the quarter, compared to the consensus estimate of $44.45 million. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. As a group, equities analysts predict that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Stephens reiterated an “overweight” rating and set a $52.00 price target on shares of Establishment Labs in a report on Thursday, March 6th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $57.40.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.